About the Authors
- Dzjemma Sarkisjan
-
Contributed equally to this work with: Dzjemma Sarkisjan, Joris R. Julsing
Affiliation Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands
- Joris R. Julsing
-
Contributed equally to this work with: Dzjemma Sarkisjan, Joris R. Julsing
Affiliation Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands
- Kees Smid
-
Affiliation Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands
- Daniël de Klerk
-
Affiliation Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands
- André B. P. van Kuilenburg
-
Affiliation Department of Clinical Chemistry, laboratory Genetic Metabolic Diseases, Academic Medical Centre, Amsterdam, Netherlands
- Rutger Meinsma
-
Affiliation Department of Clinical Chemistry, laboratory Genetic Metabolic Diseases, Academic Medical Centre, Amsterdam, Netherlands
- Young B. Lee
-
Affiliation Rexahn Pharmaceuticals, Inc., Rockville, Maryland, United States of America
- Deog J. Kim
-
Affiliation Rexahn Pharmaceuticals, Inc., Rockville, Maryland, United States of America
- Godefridus J. Peters
-
* E-mail: gj.peters@vumc.nl
Affiliation Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands
Competing Interests
YBL and DJK are employees of Rexahn Pharmaceuticals, Inc. GJP received a grant from Rexahn Pharmaceuticals, Inc. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: DS JRJ YBL DJK GJP. Data curation: DS JRJ DdK GJP. Formal analysis: DS JRJ ABPvK GJP. Funding acquisition: YBL DJK GJP. Investigation: DS JRJ DdK. Methodology: DS JRJ KS DdK RM. Project administration: DS JRJ GJP. Resources: YBL DJK GJP. Supervision: GJP. Writing – original draft: DS JRJ. Writing – review & editing: DS JRJ ABPvK YBL DJK GJP.